Clinical Trials Directory

Trials / Completed

CompletedNCT03610126

BASKA Laryngeal Mask Airway in Either Volume or Pressure Controlled Ventilation in Laparoscopic Cholecystectomy

Comparison of Efficacy of BASKA Laryngeal Mask Airway in Either Volume or Pressure Controlled Ventilation in Laparoscopic Cholecystectomy Comparative Clinical Trial

Status
Completed
Phase
Study type
Observational
Enrollment
56 (actual)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

this study will be undertaken to compare the efficacy of BASKA mask in volume controlled and pressure controlled ventilation in laparoscopic cholecystectomy.

Detailed description

Laparoscopic cholecystectomy is one of the most commonly performed surgical procedures and the laryngeal mask airway (LMA) is the most common supraglottic airway device used by the anesthesiologists to manage airway during general anesthesia. Use of LMA has some advantages when compared to endotracheal intubation, such as quick and ease of placement, a lesser requirement for neuromuscular blockade and a lower incidence of postoperative morbidity. However, the use of the LMA in laparoscopy is controversial, based on a concern about increased risk of regurgitation and pulmonary aspiration. The ability of these devices to provide optimal ventilation during laparoscopic procedures has been also questioned. The most important parameter to secure an adequate ventilation and oxygenation for the LMA under pneumoperitoneum condition is its seal pressure of airway The BASKA mask is a novel supraglottic airway device. It has many of the features of other supraglottic airways, These include; A non-inflatable cuff, that it is continuous with the central channel of the device. As the pressure increases with positive pressure ventilation, the cuff itself is 'inflated', this may improve the seal, reduce leak, and make ventilation more efficient

Conditions

Interventions

TypeNameDescription
PROCEDUREvolume controlled ventilationthe patients will be ventilated by volume controlled ventilation after insertion of the BASKA laryngeal mask airway
PROCEDUREpressure controlled ventilationthe patients will be ventilated by pressure controlled ventilation after insertion of the BASKA laryngeal mask airway

Timeline

Start date
2018-08-26
Primary completion
2022-05-08
Completion
2022-05-08
First posted
2018-08-01
Last updated
2022-05-10

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03610126. Inclusion in this directory is not an endorsement.